Edaravone suspension for oral administration | Patent Number 11241416

US 11241416 B2
Application Number17213501
Publication NumberUS 20210212990 A1
Pendency10 months, 19 days
Filled DateMar 26, 2021
Priority DateNov 1, 2019
Publication DateJul 15, 2021
Expiration DateOct 31, 2039
Inventor/ApplicantsTetsuo Hayama
Munetomo Matsuda
Tomoyuki OMURA
Tomohiro Takahashi
Tomoyuki Omura
Tadashi MIYAZAWA
Tetsuo HAYAMA
Tomohiro TAKAHASHI
Munetomo MATSUDA
Kouji Hayashi
Kouji HAYASHI
Tadashi Miyazawa
ExaminesCHANNAVAJJALA, LAKSHMI SARADA
Art Unit1611
Technology Center1600
Assignments
Mitsubishi Chemical Group Corporation
Current
Mitsubishi Chemical Group Corporation
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.